Results

eNauka >  Results >  Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial
Title: Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial
Authors: McCrimmon, Rory J.; Al Sifri, Saud; Emral, Rifat; Mohan, Viswanathan; Sauque-Reyna, Leobardo; Trescoli, Carlos; Lalić, Nebojša M. ; Alvarez, Agustina; Demil, Nacima; Coudert, Mathieu;
Shaunik, Alka; Bonnemaire, Mireille; Rosenstock, Julio;
Issue Date: 2021
Publication: Diabetes, obesity & metabolism
ISSN: 1462-8902 Diabetes Obesity and Metabolism Search Idenfier
Publisher: Oxford : Wiley-Blackwell
Type: Article
Collation: vol. 23 br. 6 str. 1221-1231
DOI: 10.1111/dom.14354
WoS-ID: 000645097200001
Scopus-ID: 2-s2.0-85103420610
PMID: 33606908
URI: https://enauka.gov.rs/handle/123456789/822844
URL: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14354
Project: Sanofi, Paris, France
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

28
SCOPUSTM
14
PubMed CentralTM
12
OpenCitations
25
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.